Updates are available Correction dated 2024-01-03
Click to view Correction: https://doi.org/10.1038/s41591-023-02771-0
Updates are available Correction dated 2023-11-27
Click to view Correction: https://doi.org/10.1038/s41591-023-02690-0
-
Authors
Fenioux, Charlotte
Abbar, Baptiste https://orcid.org/0000-0002-5907-8131
Boussouar, Samia
Bretagne, Marie
Power, John R.
Moslehi, Javid J.
Gougis, Paul
Amelin, Damien
Dechartres, Agnès
Lehmann, Lorenz H.
Courand, Pierre-Yves https://orcid.org/0000-0003-3199-7977
Cautela, Jennifer https://orcid.org/0000-0003-1284-8191
Alexandre, Joachim
Procureur, Adrien https://orcid.org/0000-0003-3486-5208
Rozes, Antoine
Leonard-Louis, Sarah
Qin, Juan https://orcid.org/0000-0002-0821-6290
,
Akhter, Nausheen
Aghel, Nazanin
Amidi, Kingsley
Anderson, Elizabeth
Arangalage, Dimitri
Aras, Mandar
Asnani, Aarti
Baldassarre, Lauren A.
Barovila, Rocio
Barroso, Ana Sofia
Bottinor, Wendy
Bouali, Anissa
Cariou, Eve
Chang, Wei-Ting
Cheng, Richard K.
Crusz, Shanthini M.
Deswal, Anita
Dietrich, Pierre-Yves
Dy, Grace
Docq, Clemence
Ewer, Steven
Fernando, Suran
Flint, Danette L.
Florido, Roberta
Fukushima, Satoshi
Galli, Elena
Gaughan, Elizabeth
Habib, Manhal
Haydon, Andrew
Heinzerling, Lucie
Ben Zadok, Osnat Itzhaki
Issa, Nahema
Karlstaedt, Anja
Kitagawa, Kazuo
Layoun, Michael
Laufer-Perl, Michal
Lenneman, Carrie
Leong, Darryl
Lesiuk, Chloe
Levenson, Joshua
López-Fernández, Teresa
Liu, Yan
Machado, Kristen
Moliner, Pedro
Morimoto, Ryota
Obeid, Michel
Narezkina, Anna
Palaskas, Nicolas
Peretto, Giovanni
Piriou, Nicolas
Plana, Juan Carlos
Rainer, Peter P.
Robert-Halabi, Maxime
Rocher, Fanny
Rota, Eugenia
Roubille, Francois
Ruf, Theresa
Sandhu, Shahneen
Sanjeev, Francis
Seki, Nobuhiko
Tajiri, Kazuko
Tamura, Yuichi
Thuny, Franck
Tresorier, Romain
Turker, Isik
Warner, Ellen
Zaha, Vlad
Zhu, Han
Cheynier, Rémi https://orcid.org/0000-0003-1146-660X
Charmeteau-De Muylder, Benedicte
Redheuil, Alban
Tubach, Florence https://orcid.org/0000-0002-7802-944X
Cadranel, Jacques
Milon, Audrey
Ederhy, Stéphane
Similowski, Thomas https://orcid.org/0000-0003-2868-9279
Johnson, Douglas B. https://orcid.org/0000-0002-6390-773X
Pizzo, Ian
Catalan, Toniemarie
Benveniste, Olivier https://orcid.org/0000-0002-1167-5797
Hayek, Salim S. https://orcid.org/0000-0003-0180-349X
Allenbach, Yves
Rosenzwajg, Michelle
Dolladille, Charles
Salem, Joe-Elie https://orcid.org/0000-0002-0331-3307
-
Funding
Funding for this research was provided by:
Direction Générale de l'offre de Soins (CIC-1901, CIC-1901)
Foundation for the National Institutes of Health (R01HL141466, R01HL155990, R01HL156021, R01HL160688, R01HL153384, R01-DK128012)
Deutsche Forschungsgemeinschaft (LE3570/2-1; 3570/3-1)
Bundesministerium für Bildung und Forschung (01KC2006B)
Fondation ARC pour la Recherche sur le Cancer
- License Information
-
More Information
Article History
Received: 6 February 2023
Accepted: 15 September 2023
First Online: 26 October 2023
Change Date: 3 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-023-02771-0
Change Date: 27 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-023-02690-0
Competing interests
: None directly related to this work. However, B. Abbar has received consultant or advisory role fees or meeting invitations from Novartis, Astellas, Sanofi, AstraZeneca, Janssen, Merck Sharp & Dohme, Pfizer, IPSEN Pharma and Takeda. J. J. Moslehi is supported by National Institutes of Health grants R01HL141466, R01HL155990, R01HL156021 and R01HL160688 and has served on advisory boards for Pfizer, Novartis, Bristol-Myers Squibb, Takeda, AstraZeneca, Myovant, Kiniksa Pharmaceuticals, BeiGene and Cytokinetics. L.H.L. has served on advisory boards for Daiichi Sankyio, Senaca, AstraZeneca and Servier; has served as an external expert for AstraZeneca; has received speakers’ honoraria from Novartis and Merck Sharp & Dohme; and is receiving grants from the German Center for Cardiovascular Research (DZHK) and the German Research Foundation (DFG) (LE3570/2-1 and 3570/3-1) and grant 01KC2006B from the Federal Ministry for Education and Research (BMBF). J. Cautela has received consultant or advisory role fees or meeting invitations from Novartis, Sanofi, AstraZeneca, Janssen, Merck Sharp & Dohme and Pfizer. F. Tubach is head of the Centre de Pharmacoépidémiologie (Cephepi) of the Assistance Publique Hôpitaux de Paris and of the Clinical Research Unit of Pitié-Salpêtrière Hospital; both of these institutions have received unrestricted research funding and grants for the research projects handled and fees for consultant activities from a large number of pharmaceutical companies that have contributed variously to small parts of the salaries of its employees. F. Tubach is not employed by these institutions and did not receive any personal remuneration from these companies. J. Cadranel has served on advisory boards or as a consultant for Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Takeda, Pfizer and Sanofi and has received research funding from AbbVie, Pfizer and Sanofi. D. Johnson has served on advisory boards or as a consultant for Bristol-Myers Squibb, Catalyst Biopharma, Iovance, Janssen, Mallinckrodt, Merck, Mosaic ImmunoEngineering, Novartis, Oncosec, Pfizer, Targovax and Teiko; has received research funding from Bristol-Myers Squibb and Incyte; and has patents pending for the use of MHC-II as a biomarker for ICI response and for abatacept as treatment for immune-related adverse events. T. Similowski reports personal fees for consulting and teaching activities from AstraZeneca France, Chiesi France, KPL Consulting, Lungpacer, OSO-AI, TEVA France and Vitalaire. He is a stock shareholder of startups Hephaï and Austral Dx. J.-E. Salem has participated on advisory boards and been a consultant for or received grants from Bristol-Myers Squibb, Novartis, AstraZeneca, CRC Oncology, EISAI and BeiGene. S.S.H. is supported by National Heart, Lung, and Blood Institute R01HL153384 and National Institute of Diabetes and Digestive and Kidney Diseases R01-DK128012. Y.A. was supported by the ARC Foundation. Other authors have nothing to disclose.
